Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Ninjurin1 enhances the basal motility and transendothelial migration of immune cells by inducing protrusive membrane dynamics.
A case of neuromyelitis optica harboring both anti-aquaporin-4 antibodies and a pathogenic mitochondrial DNA mutation for Leber's hereditary optic neuropathy.
VDJtools: Unifying Post-analysis of T Cell Receptor Repertoires.
Intrinsic third ventricular craniopharyngioma: A case report.
IL-27 Induces Th17 Differentiation in the Absence of STAT1 Signaling.
Patrolling monocytes play a critical role in CX3CR1-mediated neuroprotection during excitotoxicity.
[Remyelination strategy for multiple sclerosis].
Meta-analysis of the IL23R and IL12B polymorphisms in multiple sclerosis.
Restricted diffusion preceding gadolinium enhancement in large or tumefactive demyelinating lesions.
The Neurophysiologist Perspective into MS Plasticity.
Chances and challenges of retinoid X receptor gamma targeting for regenerative multiple sclerosis treatment.
Clinical Relevance of Serum Aquaporin-4 Antibody Levels in Neuromyelitis Optica.
Spasticity in multiple sclerosis: Associations with impairments and overall quality of life.
Objectively Quantified Physical Activity in Persons with Multiple Sclerosis.
Clinical and Magnetic Resonance Imaging (MRI) Distinctions Between Tumefactive Demyelination and Brain Tumors in Children.
New diagnostic criteria for multiple sclerosis in patients with clinically isolated syndromes: Some questions could be raised during clinical practice.
Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid cause demyelination of spinal cord explants.
Astrocyte-derived BDNF supports myelin protein synthesis after cuprizone-induced demyelination.
miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis.
Patient and Physician Perspectives on MSdialog, an Electronic PRO Diary in Multiple Sclerosis.
Recurrent optic neuritis and neuromyelitis optica-IgG following first and second human papillomavirus vaccinations.
Impairment and disability in 20 CIDP patients according to disease activity status.
Is MS an inflammatory or primary degenerative disease?
Patient education programme on immunotherapy in multiple sclerosis (PEPIMS): A controlled rater-blinded study.
Quantitative analysis of cerebrospinal fluid brain derived neurotrophic factor in the patients with multiple sclerosis.
Pages
« first
‹ previous
…
567
568
569
570
571
572
573
574
575
…
next ›
last »